News + Filings Transactions
|
Goyal Vikas
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 04/01/2021 | Pandion Therapeutics, Inc. | PAND | Disposition | Employee Stock Option (Right to Buy) | 73.8k | $17.75 | $1.3M | | 04/01/2021 |
| 04/01/2021 | Pandion Therapeutics, Inc. | PAND | Disposition | Employee Stock Option (Right to Buy) | 28.2k | $18.00 | $508.1k | | 04/01/2021 |
| 04/01/2021 | Pandion Therapeutics, Inc. | PAND | Other | Common Stock | 87.8k | $60.00 | $5.3M | | 04/01/2021 |
| 03/05/2021 | Morphic Holding, Inc. | MORF | Purchase | Common Stock | 1000 | $70.00 | $70k | | 03/05/2021 |
| 07/21/2020 | Pandion Therapeutics, Inc. | PAND | Conversion | Series B Preferred Stock | 35.9k | $0.00 | $0 | | 07/17/2020 |
| 07/21/2020 | Pandion Therapeutics, Inc. | PAND | Conversion | Common Stock | 7k | $0.00 | $0 | | 07/17/2020 |
| 07/21/2020 | Pandion Therapeutics, Inc. | PAND | Purchase | Common Stock | 1.4k | $18.00 | $26.1k | | 07/17/2020 |
| 07/17/2020 | Pandion Therapeutics, Inc. | PAND | Grant | Stock Option (right to buy) | 3.8k | $18.00 | $68.5k | | 07/17/2020 |
| 07/17/2020 | Pandion Therapeutics, Inc. | PAND | Grant | Stock Option (right to buy) | 13.9k | $18.00 | $250.8k | | 07/17/2020 |
| 07/17/2020 | Pandion Therapeutics, Inc. | PAND | Grant | Stock Option (right to buy) | 10.5k | $18.00 | $188.7k | | 07/17/2020 |
| 06/18/2020 | Morphic Holding, Inc. | MORF | Grant | Director Stock Option (right to buy) | 12k | $22.96 | $275.5k | | 06/18/2020 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Conversion | Series B Preferred Stock | 830.5k | $0.00 | $0 | By S.R. One, Limited | 07/01/2019 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Conversion | Series A Preferred Stock | 1.5M | $0.00 | $0 | By S.R. One, Limited | 07/01/2019 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Purchase | Common Stock | 333.3k | $15.00 | $5M | By S.R. One, Limited | 07/01/2019 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Conversion | Common Stock | 830.5k | $0.00 | $0 | By S.R. One, Limited | 07/01/2019 |
| 07/01/2019 | Morphic Holding, Inc. | MORF | Conversion | Common Stock | 1.5M | $0.00 | $0 | By S.R. One, Limited | 07/01/2019 |
| 11/06/2017 | Spero Therapeutics, Inc. | SPRO | Conversion | Common Stock | 244.1k | $0.00 | $0 | See Footnote | 11/06/2017 |
| 11/06/2017 | Spero Therapeutics, Inc. | SPRO | Conversion | Common Stock | 246.3k | $0.00 | $0 | See Footnote | 11/06/2017 |
| 11/06/2017 | Spero Therapeutics, Inc. | SPRO | Conversion | Common Stock | 329k | $0.00 | $0 | See Footnote | 11/06/2017 |
| 11/06/2017 | Spero Therapeutics, Inc. | SPRO | Conversion | Common Stock | 606k | $0.00 | $0 | See Footnote | 11/06/2017 |
| 11/06/2017 | Spero Therapeutics, Inc. | SPRO | Purchase | Common Stock | 428.6k | $14.00 | $6M | See Footnote | 11/06/2017 |
| 11/06/2017 | Spero Therapeutics, Inc. | SPRO | Conversion | Junior preferred stock | 1.5M | $0.00 | $0 | See Footnote | 11/06/2017 |
| 11/06/2017 | Spero Therapeutics, Inc. | SPRO | Conversion | Series A preferred stock | 982.9k | $0.00 | $0 | See Footnote | 11/06/2017 |
| 11/06/2017 | Spero Therapeutics, Inc. | SPRO | Conversion | Series B preferred stock | 1.2M | $0.00 | $0 | See Footnote | 11/06/2017 |
| 11/06/2017 | Spero Therapeutics, Inc. | SPRO | Conversion | Series C preferred stock | 3.7M | $0.00 | $0 | See Footnote | 11/06/2017 |
|